Suppliers / Farmhispania

Farmhispania

Spain 2 duplicate records merged Updated 9 July 2026

Farmhispania is an API manufacturer based in Spain. It holds 17 active US drug master files across a filed portfolio of 15 molecules. Its GMP standing is certified by US FDA, AEMPS (ES) and EMA. Its most recent recorded inspection, by US FDA, closed on 12 May 2023 as VAI.

17
active US DMFs
0
valid CEPs
2
registered plants 1 with an FDA FEI number
3
filings across 1 regulators
These figures were checked against the regulators' own files on 25 July 2026
Plants
1 of 1 confirmed
Inspections
5 of 5 confirmed
EU GMP
1 of 1 confirmed
Sources: FDA Establishment Registration, read 4 May 2026. FDA drug inspection classifications, read 4 May 2026. EudraGMDP (MIA + third-country GMP certs), read 4 May 2026.

Inspection history

  • 12 May 2023 VAI US FDA
  • 16 March 2018 VAI US FDA
  • 15 January 2016 VAI US FDA
  • 12 December 2012 VAI US FDA
  • 29 April 2009 VAI US FDA

NAI means no action indicated, VAI means voluntary action indicated, and OAI means official action indicated.

Registered plants

Site FDA FEI
Barcelona, Spain Not on file
Spain, Spain 3002806964

What they file, and where

Molecule Regulators Docs
Rocuronium SFDA (Saudi Arabia), US FDA 5
Metformin SFDA (Saudi Arabia), US FDA 3
Atracurium Besylate SFDA (Saudi Arabia), US FDA 2
Everolimus US FDA 2
Milrinone SFDA (Saudi Arabia), US FDA 2
Benazepril US FDA 1
Cisatracurium US FDA 1
Decitabine US FDA 1
Deutetrabenazine US FDA 1
Enalapril US FDA 1
Show all 15 molecules on file
Gemcitabine US FDA 1
Pemetrexed SFDA (Saudi Arabia) 1
Quinapril US FDA 1
Sugammadex US FDA 1
Tacrolimus US FDA 1

Also appears on these molecule pages

Filings and GMP by regulator

Regulator Filings GMP certificates
MINSA (CR) 3 None
US FDA None 1
AEMPS (ES) None 1
EMA None 1

Comparing suppliers?

Choose your molecules and target markets. Farmhispania comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Open risk flags

  • 1 active litigation matter is on record.
  • The most recent inspection outcome was VAI, on 12 May 2023.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability
EudraGMDP and national regulators
GMP certificates